ZHEJIANG UNIVERSITY

Clinical trials for ZHEJIANG UNIVERSITY explained in plain language.

Never miss a new study

Get alerted when new ZHEJIANG UNIVERSITY trials appear

Sign up with your email to follow new studies for ZHEJIANG UNIVERSITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Allergy pill could be new lifesaver for heart attack survivors

Disease control Recruiting now

This study is testing if a common allergy medicine, fexofenadine (like Allegra), can help people who recently had a major heart attack. It will involve 2,804 participants who will take the drug or a placebo for two years. The main goal is to see if it reduces the risk of having a…

Matched conditions: ZHEJIANG UNIVERSITY

Phase: PHASE3 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

ZHEJIANG UNIVERSITY

Get alerted when new ZHEJIANG UNIVERSITY trials appear

Allergy pill could be new lifesaver for heart attack survivors